✦ LIBER ✦

P739 RISK FACTORS AND TREATMENT OUTCOMES IN GENOTYPE 1 AND GENOTYPE 4 HEPATITIS C INFECTED PATIENTS FROM A REAL WORLD DATA ANALYSIS IN EUROPE

✍ Scribed by Moreno, C.; Horsmans, Y.; Flisiak, R.; Van Vlierberghe, H.; Trepo, E.; Starkel, P.; Jaroszewicz, J.; Geerts, A.; Pisini, M.; Lantican, L.; Koletzki, D.

Book ID: 122299669
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 67 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60900-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline factors and early viral respons

Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study

✍ Toyoda, Hidenori; Kumada, Takashi; Shimada, Noritomo; Takaguchi, Koichi; Ide, Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB

1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA

1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 OR -4 CHRONIC HEPATITIS C: SVR24 RESULTS FROM A RANDOMIZED PHASE 2B STUDY (AI447016)

✍ Bronowicki, J.-P.; Ratziu, V.; Gadano, A.; Thuluvath, P.J.; Bessone, F.; Martore 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

PIN50 The Clinical Efficacy and Cost-Eff

PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)

✍ E. Nikoglou; S. Humphreys; A. El khoury; S.A. Ferrante; C. O' Regan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB